New CEO takes the helm at biotech giant Amgen Biotech drugmaker Amgen Inc. introduced new CEO Bob Bradway to shareholders Wednesday at the company's annual meeting, with retiring CEO Kevin Sharer stepping down after a decade running the world's largest biotech company. Scientists deploy genetics in search for bigfoot LONDON (Reuters) - Scientists are turning to genetic testing to see if they can prove the existence of the elusive hairy humanoid known across the world as bigfoot, yeti and sasquatch. A joint project between Oxford University and Switzerland's Lausanne Museum of Zoology will examine organic remains that some say belong to the creature that has bee...... Gene Tests May Not Drive Patients to More Medical Care FRIDAY, May 18 (HealthDay News) -- Personal genetic testing does not lead to an increased use of health services, a new study finds. Osiris shares climb on stem-cell therapy approval Shares of Osiris Therapeutics traded higher Friday, a day after Canadian regulators approved the company's first-of-a-kind stem cell therapy Prochymal, a treatment for a deadly side effect of bone marrow transplants. Canada OKs Osiris drug; first stem cell therapy BOSTON (Reuters) - Osiris Therapeutics Inc said on Thursday that Canadian health regulators have approved its treatment for acute graft-versus host disease in children, making it the first stem cell drug to be approved for a systemic disease anywhere in the world. Osiris shares rose 14 percent to $6.00 in extended trading after the news was announc...... Canada OKs Osiris drug; first stem cell therapy BOSTON (Reuters) - Osiris Therapeutics Inc said on Thursday that Canadian health regulators have approved its treatment for acute graft-versus host disease in children, making it the first stem cell drug to be approved for a systemic disease anywhere in the world. Osiris shares rose 14 percent to $6.00 in extended trading after the news was announc...... Osiris stem cell therapy approved in Canada Osiris Therapeutics Inc. said Thursday that Canadian regulators approved its stem cell therapy Prochymal, which is intended to treat a deadly side effect of bone marrow transplants. Study unpicks gene changes behind breast cancer
B.C.'s organic growers browned off by bid to wipe browning gene from apples KELOWNA, B.C. - Orchardists in B.C.'s Okanagan region worry that the introduction of genetically modified trees could take a bite out of fruit sales. You can save this news page by submitting it to your favorite sites:
All News Lines - Local and World Wide, Updated Hourly
|

